Source: Annual Congress 2007 - Mechanisms of injury and repair in fibrotic, idiopathic or infectious lung disease
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
S. Maalej, S. BenKhamsa, L. Gharbi, N. Kourda, M. Ben Brahim, F. Tritar (Ariana, Tunis, Tunisia). Is 7.5 mg/Kg of bleomycin safe in inducing pulmonary fibrosis in wistar rats?. Eur Respir J 2007; 30: Suppl. 51, 3484

Member's Comments

No comment yet.

Related content which might interest you: Effect of simvastatin on bleomycin induced pulmonary fibrosis in rats Source: Annual Congress 2010 - Experimental approaches in pulmonary fibrosis Year: 2010 The effect of montelukast on the monocrotaline induced pulmonary disease in the wistar rat Source: Eur Respir J 2004; 24: Suppl. 48, 561s Year: 2004 Can curcuma inhibit bleomycin induced lung fibrosis in rats? Source: Annual Congress 2008 - Management of idiopathic pulmonary fibrosis: what can we learn from the pathophysiology? Year: 2008 Effect of oral administration of echinochrome on lipopolysaccharide-induced lung injury in the immature Wistar rats Source: International Congress 2019 – Identification of new targets and therapeutic strategies for lung disease Year: 2019 Effect of experimental pulmonary fibrosis induced by bleomycin on the lung fatty acid composition in Wistar rats Source: Annual Congress 2011 - Experimental models and research in diffuse parenchymal lung diseases Year: 2011 Erythropoietin (EPO) inhibits the bleomycin (BLM)-induced pulmonary fibrosis in rats Source: Annual Congress 2010 - Emerging mechanisms in lung injury Year: 2010 Attenuation by oral N-acetylcysteine of bleomycin-induced lung injury in rats Source: Eur Respir J 2001; 17: 1228-1235 Year: 2001 Effect of administration of purified fish oil on bleomycin induced lung fibrosis in rats Source: Annual Congress 2009 - A wide spectrum of idiopathic pulmonary fibrosis Year: 2009 Evolution of mediators in the CdCl2 induced fibrosis in rats Source: Eur Respir J 2004; 24: Suppl. 48, 103s Year: 2004 The effect of smoking to oxidative stress on lung tissue of rats with inhaled and intratracheal bleomycin induced pulmonary fibrosis Source: Annual Congress 2007 - Considerations in the therapeutic approach of interstitial lung disease: oxidative stress and inflammation Year: 2007 Pathological evaluation of the bleomycin induced lung injury in rats Source: Annual Congress 2008 - Animal models of pulmonary fibrosis: mechanisms and therapies Year: 2008 The effect of dexamethasone on the pulmonary fibrosis of acute lung injury induced by lipopolysaccharide in rats Source: Annual Congress 2007 - Respiratory pathophysiology Year: 2007 Effect of intermittent 0.25 ppm ozone exposure in rats with bleomycin-induced pulmonary damage Source: Eur Respir J 2002; 20: Suppl. 38, 519s Year: 2002 Effects of drotrecogin-alpha on the bleomycin-induced pulmonary fibrosis in rats Source: Annual Congress 2010 - Experimental approaches in pulmonary fibrosis Year: 2010 The effect of curcumin on bleomycin-induced pulmonary fibrosis in rats Source: Eur Respir J 2006; 28: Suppl. 50, 827s Year: 2006 Bevacizumab administration in monocrotaline induced pulmonary arterial hypertension rat model Source: Annual Congress 2010 - Pulmonary vascular diseases Year: 2010 Olodaterol attenuates bleomycin induced lung fibrosis in mice Source: International Congress 2016 – Airway pharmacology: drug targets and mode of action Year: 2016 Effects of prednisolone and imatinib mesylate on inflammation and fibrosis in amiodarone-induced pulmonary toxicity in rats Source: Annual Congress 2010 - Regulation of airway pharmacology Year: 2010 Therapeutic hypercapnia prevents pulmonary hypertension in rats with bleomycin-induced chronic neonatal lung injury Source: Annual Congress 2011 - Resuscitation and ventilation in the baby and infant Year: 2011 Effect of fasudil on the bleomycin-induced pulmonary fibrosis and hypertension in mice Source: Annual Congress 2012 - Pulmonary circulation: basic mechanisms Year: 2012